SCHEMBL22650975

SCHEMBL22650975

COC(=O)c1ccc2ccc3ccccc3c2c1-c1c(C(=O)OC)ccc2ccc3ccccc3c12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.54
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
KDM4E B2RXH2 3/20 0.53
ALDH1A1 P00352 3/20 0.53
NPSR1 Q6W5P4 2/20 0.53
HPGD P15428 1/20 0.53
MAPK10 P53779 2/20 0.48
TSHR P16473 2/20 0.48
HTT P42858 1/20 0.48
PTK2B Q14289 1/20 0.48
NCOA1 Q15788 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
NCOA3 Q9Y6Q9 1/20 0.48
WDR5 P61964 1/20 0.47
HDAC3 O15379 1/20 0.47
HDAC4 P56524 1/20 0.47
HDAC1 Q13547 1/20 0.47
HDAC7 Q8WUI4 1/20 0.47
HDAC2 Q92769 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30356865 0.88 MAPT (0.61) MAPTMEN1KMT2AKDM4EALDH1A1
SCHEMBL593520 0.88 MAPT (0.61) MAPTMEN1KMT2AKDM4EALDH1A1
SCHEMBL12486711 0.85 MAPT (0.54) MAPTMEN1KMT2AKDM4EALDH1A1
SCHEMBL7988831 0.83 MEN1 (0.48) MAPTMEN1KMT2AKDM4EALDH1A1
SCHEMBL14134529 0.82 MAPT (0.56) MAPTMEN1KMT2AKDM4EALDH1A1
SCHEMBL16384835 0.82 MAPT (0.56) MAPTMEN1KMT2AKDM4EALDH1A1
SCHEMBL17304516 0.81 MAPT (0.55) MAPTMEN1KMT2AKDM4EALDH1A1
SCHEMBL18803862 0.80 MAPT (0.67) MAPTMEN1KMT2AKDM4EALDH1A1
SCHEMBL7985137 0.80 WDR5 (0.51) MAPTMEN1KMT2AKDM4EALDH1A1
SCHEMBL246068 0.79 MAPT (0.52) MAPTMEN1KMT2AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11319266-B2 Syntheses, characterizations, and applications of heli-acenes University of Wyoming-Office of Research & Economic Development (US) 2022-05-03 US disclosed
US-20200354294-A1 SYNTHESES, CHARACTERIZATIONS, AND APPLICATIONS OF HELI-ACENES UNIVERSITY OF WYOMING (US) 2020-11-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11319266-B2 Syntheses, characterizations, and applications of heli-acenes HRH1, EHD1, CRY1 MAPT 1643/4885MEN1 3272/4885KMT2A 3604/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.